<--- Back to Details
First PageDocument Content
Multiple sclerosis / Neurological disorders / Glatiramer acetate / Syndromes / Expanded Disability Status Scale / Interferon beta-1a / Natalizumab / Clinical trial / Immunotherapy / Medicine / Health / Immunology
Multiple sclerosis
Neurological disorders
Glatiramer acetate
Syndromes
Expanded Disability Status Scale
Interferon beta-1a
Natalizumab
Clinical trial
Immunotherapy
Medicine
Health
Immunology

Add to Reading List

Source URL: msj.sagepub.com

Download Document from Source Website

File Size: 260,70 KB

Share Document on Facebook

Similar Documents

20th NSW Stem Cell Network Workshop - in collaboration with MS Research Australia Stem Cells in Multiple Sclerosis and Neurological Disease

DocID: 1vbZP - View Document

Insights into Type 1 Diabetes and Multiple Sclerosis Pathogenesis from Common Genetic Associations Sandeep K. Singh 1, Aziz A. Chentoufi 2, Jacob L. McCauley 3, Mehmet Tevfik Dorak 4 1Florida

DocID: 1vaUi - View Document

Cigarette Smoking and Incidence of Multiple Sclerosis -- Heman et al): 69 -- Ame...Page 1 of 14 Oxford Journals • ContactUs ......

DocID: 1v0yh - View Document

MULTIPLE SCLEROSIS Clues to its cause URI LEIBOWITZ Department of Neurology, Hadassah University Hospital and Hebrew U+riversity-Hada.ssah Medical School,

DocID: 1uW5T - View Document

CNS Vital Signs Advancing Multiple Sclerosis Care Adding Value to Your Practice by Providing Solutions for Measuring,  Monitoring and Managing Neurocognitive and Behavioral Health… www.CNSVS.com

DocID: 1uFcb - View Document